Large-scale testing (Phase 3)Study completedNCT00093990
What this trial is testing
Tipifarnib Versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
Who this might be right for
Acute Myeloid Leukemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 457